Skip to Main Content

Author Details

Aurora S Blucher
Knight Cancer Institute, Oregon Health Sciences University
2014
15
8
PMIDPaper TitleJournal TitlePublished Year
37596261Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer.Cell Death Dis2023
33950412Precision oncology for breast cancer through clinical trials.Clin Exp Metastasis2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
36194131IMP1/IGF2BP1 in human colorectal cancer extracellular vesicles.Am J Physiol Gastrointest Liver Physiol2022
35243422An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer.Cell Rep Med2022
34518313Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.Clin Cancer Res2021
34667258Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.NPJ Precis Oncol2021
32306787Which path to follow? Utilizing proteomics to improve therapy choices for breast cancer patients.Expert Rev Proteomics2020
32843430Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma.Cold Spring Harb Mol Case Stud2020
31596908Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma.PLoS One2019
31214023Natural Product Target Network Reveals Potential for Cancer Combination Therapies.Front Pharmacol2019
31372215Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz.F1000Res2019
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
28964549Evidence-Based Precision Oncology with the Cancer Targetome.Trends Pharmacol Sci2017
24297539Challenges in secondary analysis of high throughput screening data.Pac Symp Biocomput2014
  • 1 - 15 of 15

Recommended Authors

Lang Li
College of Medicine, The Ohio State University
Career Start Year 2018
Number of shared co-authors 0
Neel S Madhukar
Weill Cornell Medical College
Career Start Year 2015
Number of shared co-authors 0
Brent M Kuenzi
Moffitt Cancer Center
Career Start Year 2014
Number of shared co-authors 1
Elizabeth A Coker
Wellcome Sanger Institute
Career Start Year 2014
Number of shared co-authors 2
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 0
Shruti Rao
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Career Start Year 2013
Number of shared co-authors 0
Suleiman A Khan
Helsinki Institute for Information Technology (HIIT), Aalto University
Career Start Year 2012
Number of shared co-authors 6
Theodore C Goldstein
Bakar Computational Health Sciences Institute, University of California san francisco
Career Start Year 2012
Number of shared co-authors 4
Kelly Regan
The Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 0
Minjae Yoo
University of Colorado Anschutz Medical Campus
Career Start Year 2011
Number of shared co-authors 0
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Subha Madhavan
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Career Start Year 2009
Number of shared co-authors 1
Olga Nikolova
Oregon Health and Science University
Career Start Year 2007
Number of shared co-authors 13
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 4
Justin Guinney
University of Washington
Career Start Year 2006
Number of shared co-authors 9
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 3
Jonathan R Dry
Present Address: Tempus Labs Inc.
Career Start Year 2003
Number of shared co-authors 1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 2
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 1
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2002
Number of shared co-authors 0
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 3
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 1
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Tero Aittokallio
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 7
Mathew J Garnett
Wellcome Sanger Institute
Career Start Year 1998
Number of shared co-authors 4
Bissan Al-Lazikani
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 0
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 5

Collaborators

Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 8
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 6
Guanming Wu
Oregon Health and Science University
Co-authored papers 4
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 4
Molly Kulesz-Martin
Oregon Health & Science University
Co-authored papers 4
Allison L Creason
Oregon Health and Science University
Co-authored papers 3
Gabrielle Choonoo
Regeneron Pharmaceuticals
Co-authored papers 3
Nicola Long
Oregon Health and Science University
Co-authored papers 2
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 2
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 2
Jamie M Keck
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Jeremy Goecks
Oregon Health & Science University
Co-authored papers 2
Amanda d'Almeida
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 2
Elie Traer
Oregon Health & Science University
Co-authored papers 2
Russell T Burke
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
David Tyler Sweeney
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
James Dibb
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Aashis Thapa
Emory School of Medicine
Co-authored papers 2
Pierrette Lo
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Jessica Leonard
Oregon Health & Science University
Co-authored papers 2
Melissa L Abel
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Ted Laderas
Oregon Health & Science University
Co-authored papers 2
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 2
Joelle Wolf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Cody Coblentz
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Brian J Druker
Oregon Health & Science University
Co-authored papers 2
Release 1.2